159

744 Words2 Pages

In this study, mouth disintegrating tablets (MDTs) of Atenolol-Atorvastatin (AA) combination was formulated for hypertensive patients who feel difficulty in swallowing solid dosage forms especially tablets and capsules due to throat pain, vomiting, non-compliance and inconvenience. Superdisintegrants are the major players in this dosage form to impart fast disintegration. Fifteen formulations of MDT’s were prepared based on the different concentrations of two superdisintegrants (Crosscarmellose sodium and Kyron-T134). Three different techniques i.e. direct compression, effervescent and sublimation methods were used to know the effect of manufacturing processes, nature and concentration of superdisintegrants on various features of MDTs. Five formulations were made by each method. Pre-compression studies like Bulk density, Tapped density, Angle of repose, Carr’s compressibility index, Hausner’s ratio and compatibility studies such as Fourier Transform Infrared spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC) were performed. Various features such as hardness, thickness, diameter, weight variation, friability, disintegration time, dissolution studies wetting time, wetting volume, water absorption ratio, modified disintegration, uniformity of contents and stability of formulated MDT’s were evaluated. Finally results were statistically analyzed by the application of one way ANOVA test. It was observed that the formulation F13 containing Kyron-T134 (6%) and Crosscaramellose sodium (2%) found the best among all fifteen formulations in all aspects like disintegration time, wetting volume, wetting time, release studies etc. It was also observed that sublimation method is best among three methods because F13 was prepared by su...

... middle of paper ...

...se include direct compression, sublimation method, effervescent method etc. Each method has its own advantages and disadvantages but most commonly direct compression is used in preparing orodispersible tablets [8- 10].
In the present study MDT’s of Atenolol and Atorvastatin were formulated by using different techniques and superdisintegrants in order to reduce dose frequency and to enhance patient compliance towards therapy. Atenolol belongs to class β-blockers and is currently employed in the treatment of hypertension. It is also used in combination therapy of hypertension [11]. Atorvastatin is an anti-hyperlipidemic used to reduce the Cholesterol levels of the blood. This drug belongs to statins and works by inhibiting the enzyme 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase which is present in liver and plays an important role in production of cholesterol [12].

More about 159

Open Document